Hisham Ismail

Hisham Ismail is an experienced healthcare professional currently serving as the Regional Oncology Director at Accord BioPharma since June 2023. Prior to this role, Hisham held positions at Taiho Oncology, Inc. as Regional Business Director, where leadership of a team focused on launching INQOVI for MDS and growing LONSURF in metastatic colorectal cancer was pivotal. A significant tenure at Amgen involved multiple roles, culminating as Sr District Sales Manager in Hematology, where Hisham led a team in launching BLINCYTO for acute lymphoblastic leukemia. Hisham's earlier work includes leadership in commercial strategy and analysis at Amgen and Knoll Pharmaceutical, and consulting at ZS. Academic credentials include an M.B.A. from USC Marshall School of Business and a Master’s in Operations Research/Management Science from the University of Wisconsin-Madison.